Silicon Hills Wealth Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Silicon Hills Wealth Management’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$514K	Hold	716	–	–	0.29%	51
2023 Q1	$588K	Sell	716 -1	-0.1%	-$754	0.35%	49
2022 Q4	$517K	Sell	717 -10	-1%	-$7.38K	0.38%	57
2022 Q3	$501K	Buy	727 +10	+1%	+$6.29K	0.4%	52
2022 Q2	$424K	Sell	717 -88	-11%	-$57.2K	0.31%	63
2022 Q1	$562K	Sell	805 -40	-5%	-$25.3K	0.36%	62
2021 Q4	$534K	Buy	845 +111	+15%	+$68.2K	0.33%	72
2021 Q3	$444K	Buy	+734	New	+$456K	0.3%	71

Other funds holding REGN

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Silicon Hills Wealth Management's REGN Position: Q2 2023 in Review

Silicon Hills Wealth Management held its Regeneron Pharmaceuticals (REGN) position steady in Q2 2023 at 716 shares worth $514K. The position accounts for 0.29% of the portfolio, ranked #51.

Silicon Hills Wealth Management first reported a position in REGN in Q3 2021 and has held it in 8 quarters since. The position peaked at $588K in Q1 2023. 1,165 funds tracked by Wall St. Rank hold REGN as of Q2 2023.

Silicon Hills Wealth Management held 716 shares of Regeneron Pharmaceuticals worth $514K as of Q2 2023.
Silicon Hills Wealth Management left its Regeneron Pharmaceuticals share count unchanged in Q2 2023.
Regeneron Pharmaceuticals made up 0.29% of Silicon Hills Wealth Management's portfolio in Q2 2023, its #51 holding.
Silicon Hills Wealth Management first reported a position in Regeneron Pharmaceuticals in Q3 2021 and has held it in 8 quarters since.
Silicon Hills Wealth Management's Regeneron Pharmaceuticals position peaked at $588K in Q1 2023.
1,165 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2023.

Based on Silicon Hills Wealth Management's 13F filing for Q2 2023, filed 14 Aug 2023.